Style | Citing Format |
---|---|
MLA | Ma Alimohammadi Mina AMIN, et al.. "Interplay Between Lncrnas and Autophagy-Related Pathways in Leukemia: Mechanisms and Clinical Implications." Medical Oncology, vol. 42, no. 5, 2025, pp. -. |
APA | Ma Alimohammadi Mina AMIN, H Abolghasemi HASSAN, Wcs Cho William Chi SHING, Rj Reiter Russel J, A Mafi ALIREZA, M Aghagolzadeh MAHBOOBEH, K Hushmandi KIAVASH (2025). Interplay Between Lncrnas and Autophagy-Related Pathways in Leukemia: Mechanisms and Clinical Implications. Medical Oncology, 42(5), -. |
Chicago | Ma Alimohammadi Mina AMIN, H Abolghasemi HASSAN, Wcs Cho William Chi SHING, Rj Reiter Russel J, A Mafi ALIREZA, M Aghagolzadeh MAHBOOBEH, K Hushmandi KIAVASH. "Interplay Between Lncrnas and Autophagy-Related Pathways in Leukemia: Mechanisms and Clinical Implications." Medical Oncology 42, no. 5 (2025): -. |
Harvard | Ma Alimohammadi Mina AMIN et al. (2025) 'Interplay Between Lncrnas and Autophagy-Related Pathways in Leukemia: Mechanisms and Clinical Implications', Medical Oncology, 42(5), pp. -. |
Vancouver | Ma Alimohammadi Mina AMIN, H Abolghasemi HASSAN, Wcs Cho William Chi SHING, Rj Reiter Russel J, A Mafi ALIREZA, M Aghagolzadeh MAHBOOBEH, et al.. Interplay Between Lncrnas and Autophagy-Related Pathways in Leukemia: Mechanisms and Clinical Implications. Medical Oncology. 2025;42(5):-. |
BibTex | @article{ author = {Ma Alimohammadi Mina AMIN and H Abolghasemi HASSAN and Wcs Cho William Chi SHING and Rj Reiter Russel J and A Mafi ALIREZA and M Aghagolzadeh MAHBOOBEH and K Hushmandi KIAVASH}, title = {Interplay Between Lncrnas and Autophagy-Related Pathways in Leukemia: Mechanisms and Clinical Implications}, journal = {Medical Oncology}, volume = {42}, number = {5}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Ma Alimohammadi Mina AMIN AU - H Abolghasemi HASSAN AU - Wcs Cho William Chi SHING AU - Rj Reiter Russel J AU - A Mafi ALIREZA AU - M Aghagolzadeh MAHBOOBEH AU - K Hushmandi KIAVASH TI - Interplay Between Lncrnas and Autophagy-Related Pathways in Leukemia: Mechanisms and Clinical Implications JO - Medical Oncology VL - 42 IS - 5 SP - EP - PY - 2025 ER - |